Tongue squamous cell carcinoma-targeting Au-HN-1 nanosystem for CT imaging and photothermal therapy

Abstract

Tongue squamous cell carcinoma (TSCC) is a prevalent malignancy that afflicts the head and neck area and presents a high incidence of metastasis and invasion. Accurate diagnosis and effective treatment are essential for enhancing the quality of life and the survival rates of TSCC patients. The current treatment modalities for TSCC frequently suffer from a lack of specificity and efficacy. Nanoparticles with diagnostic and photothermal therapeutic properties may offer a new approach for the targeted therapy of TSCC. However, inadequate accumulation of photosensitizers at the tumor site diminishes the efficacy of photothermal therapy (PTT). This study modified gold nanodots (AuNDs) with the TSCC-targeting peptide HN-1 to improve the selectivity and therapeutic effects of PTT. The Au-HN-1 nanosystem effectively targeted the TSCC cells and was rapidly delivered to the tumor tissues compared to the AuNDs. The enhanced accumulation of photosensitizing agents at tumor sites achieved significant PTT effects in a mouse model of TSCC. Moreover, owing to its stable long-term fluorescence and high X-ray attenuation coefficient, the Au-HN-1 nanosystem can be used for fluorescence and computed tomography imaging of TSCC, rendering it useful for early tumor detection and accurate delineation of surgical margins. In conclusion, Au-HN-1 represents a promising nanomedicine for imaging-based diagnosis and targeted PTT of TSCC.

References

[1.] Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma—an update. CA Cancer J. Clin., 2015, 65: 401-421

[2.] Feng H, Zhang X, Lai W, Wang J. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma. Cell Cycle, 2020, 19: 1641-1653

[3.] Gray JL, Maghlouth AA, Hussain HA, Sheef MA. Impact of oral and oropharyngeal cancer diagnosis on smoking cessation patients and cohabiting smokers. Tob. Induc. Dis., 2019, 17 75

[4.] Erber, R. et al. Impact of spatially heterogeneous Trop-2 expression on prognosis in oral squamous cell carcinoma. Int. J. Mol. Sci. 23 https://doi.org/10.3390/ijms23010087(2021).

[5.] Society of Oral Maxillofacial Head and Neck Oncology, Chinese Stomatological Association. Expert consensus on surgical treatment of tongue squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi 57, 836–848 (2022).

[6.] Li Z, et al.. Development of photocontrolled BRD4 PROTACs for tongue squamous cell carcinoma (TSCC). Eur. J. Med. Chem., 2021, 222 113608

[7.] Li, N. et al. Whole-exome sequencing reveals genetic underpinnings of salivary adenoid cystic carcinoma and tongue carcinoma in Chinese population. Cancer Res. 80 https://doi.org/10.1158/1538-7445.Am2020-lb-310 (2020).

[8.] Stepan KO, et al.. Changing epidemiology of oral cavity cancer in the United States. Otolaryngol. Head Neck Surg., 2023, 168: 761-768

[9.] Zhang H, et al.. Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population. J. Pathol., 2020, 251: 353-364

[10.] Liu X, et al.. Sox2 promotes tumor aggressiveness and epithelial‑mesenchymal transition in tongue squamous cell carcinoma. Int. J. Mol. Med., 2018, 42: 1418-1426

[11.] Zhu L, et al.. Surgical treatment of early tongue squamous cell carcinoma and patient survival. Oncol. Lett., 2019, 17: 5681-5685

[12.] Oikawa Y, et al.. Surgical treatment for oral tongue squamous cell carcinoma: a retrospective study of 432 patients. Glob. Health Med., 2021, 3: 157-162

[13.] Yan H, et al.. Tongue squamous cell carcinoma discrimination with Raman spectroscopy and convolutional neural networks. Vib. Spectrosc., 2019, 103 102938

[14.] Li, Z. et al. Intraoperative rapid assessment of the deep muscle surgical margin of tongue squamous cell carcinoma via Raman spectroscopy. Front. Bioeng. Biotechnol. 12 https://doi.org/10.3389/fbioe.2024.1480279 (2024).

[15.] Hainfeld JF, et al.. Gold nanoparticle hyperthermia reduces radiotherapy dose. Nanomedicine, 2014, 10: 1609-1617

[16.] Nejabat M, et al.. An overview on gold nanorods as versatile nanoparticles in cancer therapy. J. Control Release, 2023, 354: 221-242

[17.] Cui X, et al.. Photothermal nanomaterials: a powerful light-to-heat converter. Chem. Rev., 2023, 123: 6891-6952

[18.] Cao, L., Wu, Y., Shan, Y., Tan, B. & Liao, J. A review: potential application and outlook of photothermal therapy in oral cancer treatment. Biomed. Mater. 17 https://doi.org/10.1088/1748-605X/ac5a23 (2022).

[19.] Menon JU, et al.. Nanomaterials for photo-based diagnostic and therapeutic applications. Theranostics, 2013, 3: 152-166

[20.] Xia L, et al.. Nitroxide-radicals-modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy. Int. J. Nanomed., 2018, 13: 7123-7134

[21.] Duan S, et al.. Nanomaterials for photothermal cancer therapy. RSC Adv., 2023, 13: 14443-14460

[22.] Yang Y, et al.. Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy. J. Nanobiotechnol., 2021, 19 54

[23.] Khademi Z, et al.. Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells. Carbohydr. Polym., 2020, 248 116735

[24.] Libutti SK, et al.. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res., 2010, 16: 6139-6149

[25.] Kumthekar, P. et al. A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Sci. Transl. Med. 13 https://doi.org/10.1126/scitranslmed.abb3945 (2021).

[26.] Goddard ZR, Marín MJ, Russell DA, Searcey M. Active targeting of gold nanoparticles as cancer therapeutics. Chem. Soc. Rev., 2020, 49: 8774-8789

[27.] Li R, et al.. Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy. Sci. Rep., 2021, 11 1725

[28.] Dudas J, Idler C, Sprinzl G, Bernkop-Schnuerch A, Riechelmann H. Identification of HN-1-peptide target in head and neck squamous cell carcinoma cells. ISRN Oncol., 2011, 2011 140316

[29.] Hong FD, Clayman GL. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res., 2000, 60: 6551-6556

[30.] Wright CL, Pan Q, Knopp MV, Tweedle MF. Advancing theranostics with tumor-targeting peptides for precision otolaryngology. World J. Otorhinolaryngol. Head Neck Surg., 2016, 2: 98-108

[31.] Wang Y, et al.. PEGylated doxorubicin nanoparticles mediated by HN-1 peptide for targeted treatment of oral squamous cell carcinoma. Int. J. Pharm., 2017, 525: 21-31

[32.] Yang, Z. et al. Ultrasmall red fluorescent gold nanoclusters for highly biocompatible and long-time nerve imaging. Part. Part. Syst. Charact. 38 https://doi.org/10.1002/ppsc.202100001 (2021).

[33.] Wang Z, et al.. Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer. Acta Biomater., 2023, 166: 581-592

[34.] Sun Q, et al.. Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer. J. Mater. Chem. B, 2020, 8: 7253-7263

[35.] Liu, D. et al. HOCl-activated aggregation of gold nanoparticles for multimodality therapy of tumors. Adv. Sci. 8 https://doi.org/10.1002/advs.202100074 (2021).

[36.] Kim, H. S. & Lee, D. Y. Near-infrared-responsive cancer photothermal and photodynamic therapy using gold nanoparticles. Polymers 10 https://doi.org/10.3390/polym10090961 (2018).

[37.] Cheng, X. J. et al. Light-triggered assembly of gold nanoparticles for photothermal therapy and photoacoustic imaging of tumors in vivo. Adv. Mater. 29 https://doi.org/10.1002/adma.201604894 (2017).

[38.] Hu, Y. et al. Preparation of photothermal responsive and ROS generative gold nanocages for cancer therapy. Chem. Eng. J. 421 https://doi.org/10.1016/j.cej.2021.129744 (2021).

[39.] Chen, J. et al. Furin-instructed intracellular gold nanoparticle aggregation for tumor photothermal therapy. Adv. Funct. Mater. 30 https://doi.org/10.1002/adfm.202001566 (2020).

[40.] Huang L, et al.. FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma. Int. J. Biol. Sci., 2019, 15: 2330-2339

[41.] Liu M, et al.. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis. Cell Death Dis., 2021, 12 144

[42.] Cai X, Huang J. Distant metastases in newly diagnosed tongue squamous cell carcinoma. Oral Dis., 2019, 25: 1822-1828

[43.] Jimenez L, Jayakar SK, Ow TJ, Segall JE. Mechanisms of invasion in head and neck cancer. Arch. Pathol. Lab. Med., 2015, 139: 1334-1348

[44.] Ye Y, et al.. Computed tomography/magnetic resonance imaging for mandibular boundary invasion of oral squamous cell carcinoma assessment. BMC Oral. Health, 2024, 24 172

[45.] Ali MR, et al.. Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice. Proc. Natl Acad. Sci. USA, 2017, 114: E3110-e3118

[46.] Pérez-Hernández M, et al.. Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms. ACS Nano, 2015, 9: 52-61

[47.] Liu K, et al.. Enhanced mild-temperature photothermal therapy by pyroptosis-boosted ATP deprivation with biodegradable nanoformulation. J. Nanobiotechnol., 2023, 21 64

[48.] Yang G, et al.. Ligand engineering of Au(44) nanoclusters for NIR-II luminescent and photoacoustic imaging-guided cancer photothermal therapy. Chem. Sci., 2023, 14: 4308-4318

[49.] Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc., 2006, 128: 2115-2120

[50.] Neshastehriz A, Tabei M, Maleki S, Eynali S, Shakeri-Zadeh A. Photothermal therapy using folate conjugated gold nanoparticles enhances the effects of 6MV X-ray on mouth epidermal carcinoma cells. J. Photochem. Photobiol. B Biol., 2017, 172: 52-60

[51.] Liu X, et al.. Tumor-targeted multimodal optical imaging with versatile cadmium-free quantum dots. Adv. Funct. Mater., 2016, 26: 267-276

[52.] Hong FU, Castro M, Linse K. Tumor specifically internalizing peptide ‘HN-1’: targeting the putative receptor retinoblastoma-regulated discoidin domain receptor 1 involved in metastasis. World J. Clin. Oncol., 2022, 13: 323-338

[53.] Xu X, et al.. Multifunctional nanotheranostic gold nanocages for photoacoustic imaging guided radio/photodynamic/photothermal synergistic therapy. Acta Biomater., 2019, 84: 328-338

[54.] Lin B, et al.. Peptide functionalized upconversion/NIR II luminescent nanoparticles for targeted imaging and therapy of oral squamous cell carcinoma. Biomater. Sci., 2021, 9: 1000-1007

[55.] Kong F-Y, et al.. Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules, 2017, 22: 1445

Funding

National Key Research and Development Program of China (2021YFC2400603) and the Joint Funds of the National Natural Science Foundation of China (Grant No. U23A20269).; Science and Technology Projects of Jilin Provincial Department of science and technology (Grant/Award Numbers: 20240305037YY)